As of April 2024 Axon Enterprise has a market cap of $23.10 Billion. This makes Axon Enterprise the world's 814th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $23.10 B | 19.38% |
2023 | $19.35 B | 63.93% |
2022 | $11.80 B | 9.85% |
2021 | $10.74 B | 37.58% |
2020 | $7.81 B | 79.2% |
2019 | $4.35 B | 69.45% |
2018 | $2.57 B | 83.5% |
2017 | $1.40 B | 10.64% |
2016 | $1.26 B | 36.51% |
2015 | $0.92 B | -33.85% |
2014 | $1.40 B | 67.62% |
2013 | $0.83 B | 77.48% |
2012 | $0.47 B | 65.78% |
2011 | $0.28 B | -3.31% |
2010 | $0.29 B | 8.17% |
2009 | $0.27 B | -16.5% |
2008 | $0.32 B | -64.04% |
2007 | $0.90 B | 93.15% |
2006 | $0.46 B | 8.81% |
2005 | $0.43 B | -77.67% |
2004 | $1.93 B | 454.7% |
2003 | $0.34 B | 2955.13% |
2002 | $11.39 M | -70.35% |
2001 | $38.41 M |
On Apr 25th, 2024 the market cap of Axon Enterprise was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
XBiotech XBIT | $0.25 B | -98.92% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $0.10 B | -99.55% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | -98.01% | ๐บ๐ธ USA |
Exelixis EXEL | $6.93 B | -69.98% | ๐บ๐ธ USA |